Ventyx Biosciences Stock Current Valuation
| VTYX Stock | USD 2.65 0.11 4.33% |
Valuation analysis of Ventyx Biosciences helps investors to measure Ventyx Biosciences' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to drop to -0.53 in 2024. Enterprise Value Multiple is likely to drop to -0.53 in 2024. Fundamental drivers impacting Ventyx Biosciences' valuation include:
Price Book 0.6722 | Enterprise Value -76.4 M | Enterprise Value Ebitda (22.93) |
Undervalued
Today
Please note that Ventyx Biosciences' price fluctuation is somewhat reliable at this time. Calculation of the real value of Ventyx Biosciences is based on 3 months time horizon. Increasing Ventyx Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ventyx Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ventyx Stock. However, Ventyx Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.65 | Real 15.48 | Target 54.6 | Hype 2.66 | Naive 2.99 |
The intrinsic value of Ventyx Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ventyx Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ventyx Biosciences helps investors to forecast how Ventyx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ventyx Biosciences more accurately as focusing exclusively on Ventyx Biosciences' fundamentals will not take into account other important factors: Ventyx Biosciences Company Current Valuation Analysis
Ventyx Biosciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Ventyx Biosciences Current Valuation | (76.41 M) |
Most of Ventyx Biosciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ventyx Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Ventyx Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Ventyx Biosciences is extremely important. It helps to project a fair market value of Ventyx Stock properly, considering its historical fundamentals such as Current Valuation. Since Ventyx Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ventyx Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ventyx Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Ventyx Current Valuation Historical Pattern
Today, most investors in Ventyx Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ventyx Biosciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Ventyx Biosciences current valuation as a starting point in their analysis.
Ventyx Biosciences Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Ventyx Biosciences has a Current Valuation of (76.41 Million). This is 100.53% lower than that of the Pharmaceuticals sector and 101.64% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.46% higher than that of the company.
Ventyx Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ventyx Biosciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ventyx Biosciences could also be used in its relative valuation, which is a method of valuing Ventyx Biosciences by comparing valuation metrics of similar companies.Ventyx Biosciences is currently under evaluation in current valuation category among its peers.
Ventyx Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Ventyx Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Ventyx Biosciences' managers, analysts, and investors.Environmental | Governance | Social |
Ventyx Fundamentals
| Return On Equity | -0.54 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | (76.41 M) | ||||
| Shares Outstanding | 70.71 M | ||||
| Shares Owned By Insiders | 4.01 % | ||||
| Shares Owned By Institutions | 84.93 % | ||||
| Number Of Shares Shorted | 8.55 M | ||||
| Price To Book | 0.67 X | ||||
| EBITDA | (207.99 M) | ||||
| Net Income | (192.96 M) | ||||
| Cash And Equivalents | 250.45 M | ||||
| Cash Per Share | 4.92 X | ||||
| Total Debt | 12.51 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 14.27 X | ||||
| Book Value Per Share | 3.94 X | ||||
| Cash Flow From Operations | (166.52 M) | ||||
| Short Ratio | 9.33 X | ||||
| Earnings Per Share | (2.35) X | ||||
| Target Price | 11.14 | ||||
| Number Of Employees | 75 | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 187.38 M | ||||
| Total Asset | 277.69 M | ||||
| Retained Earnings | (419.19 M) | ||||
| Working Capital | 242.08 M | ||||
| Net Asset | 277.69 M |
About Ventyx Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ventyx Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ventyx Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ventyx Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Ventyx Stock Analysis
When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.